An overdose of levothyroxine does not always manifest as clear tachycardia or visible tremors. In many patients, the initial signs are insidious: unusual irritability, fragmented insomnia, accelerated transit without identifiable dietary cause. Recognizing these early signals and adjusting management prevents escalation to cardiovascular or bone complications.
Iatrogenic Thyrotoxicosis: Distinguishing Acute Overdose from Chronic Excess
Levothyroxine is a medication with a narrow therapeutic margin. Even a slight variation in the absorbed dose can shift a patient from an euthyroid state to iatrogenic hyperthyroidism. We distinguish two very different clinical pictures based on timing.
See also : How to Extend the Lifespan of Your Irrigation Timer Batteries
Acute overdose (accidental ingestion of a massive dose) remains rare and causes a rapid rise in free T4 levels, along with tachycardia, agitation, and hyperthermia. Management then falls under medical emergency.
Chronic overdose is significantly more common and more insidious. It develops over several weeks, often after a poorly reassessed dose adjustment. TSH gradually drops below the lower limit without the patient experiencing clear symptoms. This situation poses the most problems in practice because it remains silent for a long time.
Further reading : How to Choose the Ideal Sports Equipment to Improve Your Performance
When questioning the effects of a too high levothyroxine dosage, it is often this scenario of gradual drift that is at play, rather than a one-time dosing error.
Long-term Adverse Effects of Levothyroxine Overdose
The consequences of a persistently suppressed TSH far exceed daily discomfort. Three axes of complications deserve particular attention.
Increased Cardiovascular Risk
Chronic iatrogenic hyperthyroidism increases resting heart rate and promotes atrial fibrillation, even in patients without a cardiac history. The risk of atrial fibrillation is significantly higher when TSH remains low for several months.
Accelerated Bone Loss
Excess levothyroxine stimulates bone remodeling. In particular, in postmenopausal women, prolonged overdose accelerates demineralization and increases fracture risk. This point is often underestimated during follow-up in general practice.
Cognitive Decline Risk in the Elderly
A cohort published in 2024 in Neurology (Moon JH et al.) highlighted that a suppressed TSH, even related to treatment, is associated with a higher risk of dementia in those over 65. This finding reinforces the need to quickly correct excessive dosing in elderly patients, even in the absence of loud symptoms.
Levothyrox Overdose After Thyroid Cancer: Practices Under Review
For years, the voluntary suppression of TSH through high doses of levothyroxine was the norm after thyroidectomy for differentiated cancer. This approach is changing.
The 2022 recommendations from the European Thyroid Association emphasize the reduction of TSH suppression degree in low-risk recurrence patients. In practice, maintaining an almost zero TSH is no longer justified for most patients operated on for low-risk cancer, due to documented cardiovascular and bone adverse effects.
We recommend that patients in this situation ask their endocrinologist for a reassessment of the target suppression level, especially if the suppressive treatment has lasted for several years without reclassification of recurrence risk.
What to Do in Case of Levothyroxine Overdose Signs
The appropriate response depends on the severity of the symptoms and the clinical context. Here are the steps we recommend.
- Check TSH and free T4 without waiting for the next scheduled appointment. A delay of several weeks between the onset of symptoms and biological testing worsens the consequences of the overdose.
- Never modify the levothyroxine dose without medical advice. A too abrupt reduction can cause a rebound of hypothyroidism with symptoms sometimes more debilitating than the initial overdose.
- Inform the doctor of any recently added medication or dietary supplement. Some molecules (proton pump inhibitors, iron, calcium) alter the absorption of levothyroxine and can shift the therapeutic balance without a change in dose.
- Report adverse effects to the regional pharmacovigilance center. This process contributes to post-marketing surveillance and remains underutilized in practice.
Drug Interactions to Check as a Priority
Some patients tolerate a stable dosage for months, then develop signs of overdose after the introduction of a new treatment. Medications containing magnesium, iron, or calcium reduce the intestinal absorption of levothyroxine if taken close together. Conversely, stopping these treatments can increase the bioavailability of levothyroxine and cause a relative excess without changing the prescribed dose.
Another common pitfall concerns significant weight gain or loss. The necessary dose of levothyroxine is correlated with body weight. A notable weight loss necessitates a reevaluation of the dosage, otherwise the patient may find themselves in relative overdose.
Optimal Biological Monitoring to Prevent Levothyroxine Overdose
TSH alone is not always sufficient to correctly assess thyroid status. We regularly observe patients whose TSH remains in a low gray zone while free T4 is clearly elevated. Systematically combining TSH and free T4 during monitoring allows for a more nuanced reading of the situation.
After any dose adjustment, a minimum delay of six weeks is necessary before rechecking biology. This delay corresponds to the time required for the thyrotropic axis to equilibrate. Testing too early yields uninterpretable results and often leads to unnecessary corrections.
In elderly patients or those with cardiovascular risk factors, we recommend biological monitoring every three to four months rather than the usual six-month rhythm. The margin between therapeutic efficacy and overdose narrows with age, and tolerance to excess decreases proportionally.
Levothyroxine overdose remains a underdiagnosed issue, largely because its chronic manifestations mimic other pathologies. A patient complaining of palpitations, anxiety, or paradoxical fatigue while on thyroid treatment deserves rapid biological testing rather than a referral to another specialty.